ES2130069A1 - Preparacion farmaceutica con liberacion retardada del producto activo. - Google Patents

Preparacion farmaceutica con liberacion retardada del producto activo.

Info

Publication number
ES2130069A1
ES2130069A1 ES09700765A ES9700765A ES2130069A1 ES 2130069 A1 ES2130069 A1 ES 2130069A1 ES 09700765 A ES09700765 A ES 09700765A ES 9700765 A ES9700765 A ES 9700765A ES 2130069 A1 ES2130069 A1 ES 2130069A1
Authority
ES
Spain
Prior art keywords
delayed release
active ingredient
pharmaceutical preparation
solvent
surfactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09700765A
Other languages
English (en)
Other versions
ES2130069B1 (es
Inventor
Grau Jose Ramon Tico
Negre Jose Maria Sune
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Labiana Life Sciences SA
Original Assignee
BASF Labiana SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF Labiana SA filed Critical BASF Labiana SA
Priority to ES9700765A priority Critical patent/ES2130069B1/es
Priority to EP98106425A priority patent/EP0872232A1/de
Publication of ES2130069A1 publication Critical patent/ES2130069A1/es
Application granted granted Critical
Publication of ES2130069B1 publication Critical patent/ES2130069B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Abstract

Preparación farmacéutica con liberación retardada del producto activo y su empleo para la fabricación de soluciones inyectables para el tratamiento terapéutico de animales, cuya preparación comprende: a)un producto activo, b)un agente formador de gel, c)un tampón, d)una substancia tensioactiva.
ES9700765A 1997-04-10 1997-04-10 Preparacion farmaceutica con liberacion retardada del producto activo. Expired - Fee Related ES2130069B1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES9700765A ES2130069B1 (es) 1997-04-10 1997-04-10 Preparacion farmaceutica con liberacion retardada del producto activo.
EP98106425A EP0872232A1 (de) 1997-04-10 1998-04-08 Pharmazeutische Zubereitung mit verzögerter Wirkstofffreigabe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9700765A ES2130069B1 (es) 1997-04-10 1997-04-10 Preparacion farmaceutica con liberacion retardada del producto activo.

Publications (2)

Publication Number Publication Date
ES2130069A1 true ES2130069A1 (es) 1999-06-16
ES2130069B1 ES2130069B1 (es) 2000-03-01

Family

ID=8298911

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9700765A Expired - Fee Related ES2130069B1 (es) 1997-04-10 1997-04-10 Preparacion farmaceutica con liberacion retardada del producto activo.

Country Status (2)

Country Link
EP (1) EP0872232A1 (es)
ES (1) ES2130069B1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106309409B (zh) * 2016-09-29 2019-05-24 乐山市瑞和祥动物保健药业有限公司 一种酒石酸泰乐菌素预混剂组合物的缓释微丸制备方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE825656A (fr) * 1974-02-19 1975-08-18 Solution d'oxytetracycline et procede permettant de la preparer
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
GB2136293A (en) * 1983-03-11 1984-09-19 Richter Gedeon Vegyeszet Antiinflammatory compositions
US5075295A (en) * 1989-12-12 1991-12-24 Boehringer Ingelheim Animal Health, Inc. Novel oxytetracycline compositions
WO1994021267A1 (en) * 1993-03-24 1994-09-29 Norbrook Laboratories Limited Tylosin containing sustained release veterinary compositions
WO1996001634A1 (en) * 1994-07-09 1996-01-25 Norbrook Laboratories Limited Long-acting oxytetracycline composition

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE825656A (fr) * 1974-02-19 1975-08-18 Solution d'oxytetracycline et procede permettant de la preparer
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
GB2136293A (en) * 1983-03-11 1984-09-19 Richter Gedeon Vegyeszet Antiinflammatory compositions
US5075295A (en) * 1989-12-12 1991-12-24 Boehringer Ingelheim Animal Health, Inc. Novel oxytetracycline compositions
WO1994021267A1 (en) * 1993-03-24 1994-09-29 Norbrook Laboratories Limited Tylosin containing sustained release veterinary compositions
WO1996001634A1 (en) * 1994-07-09 1996-01-25 Norbrook Laboratories Limited Long-acting oxytetracycline composition

Also Published As

Publication number Publication date
EP0872232A1 (de) 1998-10-21
ES2130069B1 (es) 2000-03-01

Similar Documents

Publication Publication Date Title
AU7207098A (en) Stabilization of acid sensitive benzimidazols with amino acid/cyclodextrin combinations
HK1018396A1 (en) Delivery system of an active agent.
AU4617797A (en) Solid foamed active substance preparations
PL335575A1 (en) Hydrophilic two-component systems for use in administration of cyclosporine
MY100721A (en) Therapeutic agent.
CA2004598A1 (en) Medicinal aerosol formulations
MX9304975A (es) Una composicion en polvo para inhalacion y procedimiento para preparar la misma.
DK0695172T3 (da) Fast præparat med hurtig frigørelse, dets fremstilling og dets anvendelse
WO1999002133A3 (en) Topical application of a combination of benzoyl peroxide and a second active ingredient
AU1086601A (en) Formulations for delivery of osteogenic proteins
AU698240B2 (en) Composition providing selective release of an active ingredient
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
HK1040920A1 (en) Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent.
ZA200007415B (en) Amino acid derivatives and drugs containing the same as the active ingredient.
WO1997028104A8 (de) Puffersysteme zur stabilisierung pharmazeutischer zubereitungen
NO985145D0 (no) Farmas°ytiske preparater for forsinket frigj°ring av uoppl°selige, aktive bestanddeler
ATE262911T1 (de) Pharmazeutische präparate, insbesondere ovula, die viele verschiedene aktive bestandteile enthalten
AU6386801A (en) System for the release of active ingredients
ES2130069A1 (es) Preparacion farmaceutica con liberacion retardada del producto activo.
HRP20020165B1 (en) Low-dose tablets and preparation method
AU2651297A (en) Indolyl-substituted uracil derivatives and herbicides comprising them as active ingredients
ES2131482A1 (es) Formulacion acuosa de bambuterol.
RS50074B (sr) Farmaceutski preparat koji sadrži paracetamol i drotaverin
AU1092095A (en) Intra-uterine ring for the release of an active agent, such as a hormone, and an introducer
ZA9711336B (en) Sulfonamido or carboamido derivatives and pharmaceutical composition containing them as an active ingredient.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990616

Kind code of ref document: A1

Effective date: 19990616

FD1A Patent lapsed

Effective date: 20040503